spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

12th annual Cold Chain Distribution Conference and Exhibition

Cold Chain Distribution Conference and Exhibition

13-14 December 2017
Copthorne Tara Hotel, London, UK

As the global healthcare industry grows, temperature controlled logistics rapidly evolves along with it. Factors such as the ever-changing regulatory requirements, diverse array of biopharma products entering the markets, and new technology emerging daily, are causing companies to face the challenge of constantly adapting their supply chain processes and staying ahead of the curve.

Responding to the evolution within the industry, SMi is proud to announce the return of its leading 12th annual Cold Chain Distribution event. Returning to London in December, this year's event will remain at the forefront of innovation.

There has been a recent surge in temperature sensitive products entering the supply chain and the need for a streamlined temperature controlled supply chain has never been more important. Cold Chain Distribution 2017 looks at why companies must revisit their logistics, quality, and security procedures implemented to ensure they are keeping pace with this exponential growth. With huge interest from leaders in the field, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Cold Chain Distribution event.

The event will look at the fundamental question of how to keep costs low & quality high, while remaining compliant to global regulations.

 

Key topics for 2017 include:

  • GPS temperature monitoring 
  • Temperature data management 
  • Temperature controlled freight options 
  • GDP Regulatory Requirements
  • Identifying Future Trends


This year's event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers:

  • Tony Wright, CEO, Exelsius 
  • Bob Hayes, Director, SeerPharma (UK)  
  • Chris Wallace, Senior Director - International Supply Chain, Sanofi Genzyme 
  • David Spillett, Key Account Director, World Courier 
  • Mark Edwards, Managing Director, Modalis Ltd.  
  • Amélie Ermel, Production Senior Specialist Associate, Eli Lilly  
  • Stephanie Fitt, Sales Manager UK & Scandinavia, EMBALL'ISO 
  • Stephen Mitchell, Quality Lead Logistics Partnership, GlaxoSmithKline 
  • Umit Kartoglu, Scientist, World Health Organization 
  • Martin  Fitzgerald, Deputy Director General, European Association of Pharmaceutical Full Line-Wholesalers (GIRP) 
  • Glyn Stacey, Director of the UK Stem Cell Bank, National Institute For Biological Standards And Control 
  • Tim Wood, Technical Service Manager, GlaxoSmithKline 
  • Gianpiero Lorusso, Supply Chain Director, Merck S.p.A

12th annual Cold Chain Distribution Conference and Exhibition

13th -14th December 2017

Copthorne Tara Hotel, London, UK

Email: events@smi-online.co.uk

Tel: +44 (0) 207 827 6012

www.coldchain-distribution.com/samedan

 

phone Tel: +44 (0) 207 827 6012
email events@smi-online.co.uk
web www.coldchain-distribution.com/samedan
email Copthorne Tara Hotel, London, UK
 
Print this page
Send to a friend
   
spacer
Industry Events

Drug Discovery 2018

21-22 March 2018, Copthorne Tara Hotel, Scarsdale Place, Kensington, London

SMi Group is proud to announce the return of Drug Discovery in 2018. The successful conference will return for its 2nd year on the 21st and 22nd March.
More info >>

Banner of Clinical_Trial_New_England_events_95 on Samedan Banner of T3_events_97 on Samedan Banner of ChinaBio_Events_102 on Samedan

White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>


News and Press Releases

Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 1, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure. Through the agreement, Charles River will perform HTS programs for its clients utilizing AstraZeneca’s state-of-the-art HTS facility.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement